News
Stay informed on the latest clinical milestones, media coverage, and partnerships from J3 Bioscience.
Explore how our IVR platform continues to drive new opportunities for hormone-free innovation in women’s health.
A Thank You to Our LivRing Community ❤️
J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness
J3 Bioscience appoints Dr. Stephanie Singer as medical director
Consumers find LivRing effectively addresses needs for vaginal dryness relief.
The findings demonstrate the effectiveness of LIV-Ring in addressing symptoms commonly associated with vaginal dryness – the second most common symptom of menopause – offering a meaningful new option to women seeking clinically tested, non-hormonal, and readily accessible solutions.
J3 Bioscience, Inc. announces appointment of new director to board
J3 Bioscience, Inc., a commercialization stage women’s health medical device company, today announced the appointment of Dr. Sheryl A. Kingsberg to its Board of Directors.